Drug
Xmt 1001
Xmt 1001: highest development phase Phase 1, developed by Mersana Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Mersana Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| XMT-1001 NCT00455052 | Phase 1 | Small Cell Lung Cancer |
Latest
No recent events.
Follow Xmt 1001 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.